The Venture Codex

Participated · Seed · Jun 2026

BoolSi offers a compilation platform that automatically synthesizes software functions into custom digital logic, producing dedicated coprocessors (hardware agents) as standard compilation output. Its tooling is designed to let users compile software onto silicon by generating custom hardware accelerators from ordinary code. The platform aims to overcome traditional chip design hurdles by delivering generated hardware as part of the compilation flow. BoolSi is headquartered in Boston, MA. Following its seed raise, the company plans to expand operations and accelerate product development using the new funds. The articles do not disclose revenue, user metrics, or other financial performance details.

Led · Equity · Dec 2025

Founded in 2020 by father-and-daughter duo Prof. Gordan Lauc and Nikolina Lauc, England-based GlycanAge analyzes glycans—complex sugars that coat cells and many proteins—to read inflammation-linked signals that drive ageing. Its flagship offering is an IgG glycosylation-based “inflammaging” clock that provides a detailed measure of biological age and tracks how lifestyle, environmental factors and chronic inflammation affect health over time. The company is now building indication-specific clinical tools for stress and resilience, cardiometabolic health, weight management and hormones, with plans to package these as products for practitioners. It is also validating diagnostic indications and preparing its first lab-developed tests for hospital and reference-lab use, supported by collaborations with Northwestern University Hospital and Mayo Clinic. A pilot is already live at St Catherine Specialty Hospital in Zagreb, and GlycanAge intends to roll out to more than 10 hospitals across Europe and the Middle East within a year. In Saudi Arabia, a partnership with the King Abdulaziz City for Science and Technology will host the firm’s first local laboratory to serve regional hospital networks. The company has raised at least €11.3 million to date, including a €3.9 million seed round in 2024 and the latest €7.4 million financing.

Participated · Equity · Apr 2025

Wasp is an open-source platform that acts as the glue between fragmented web development tools, compiling technologies such as React, Node.js and Prisma into one full-stack application. Founded by Matija and Martin Šošić and launched in 2021, Wasp is built as a layer on top of existing tooling so developers do not need to learn a new language or process. The platform detects common integration gaps (for example missing API keys) and suggests code changes to improve security and scalability, addressing risks from novice 'vibe coding.' Wasp can deploy to public cloud or enterprise servers and reports usage across numerous startups and Fortune 500 customers. The product entered beta in 2023 and has accumulated 26,000 GitHub stars. Financially, the company has raised $5.2M to date and says it will use new funding to focus on product development toward a v1.0 with features like multi-language support and server-side rendering. Wasp provides a simple configuration language and tooling layer that sits on top of existing stacks (React, Node.js) to speed up building full‑stack web applications. The product is open source and currently in alpha, available on GitHub. Founders Matija and Martin Sosic started the company in Croatia in 2019 and later joined Y Combinator (Winter 2021). Wasp reports about 300 apps have been built using the tool so far. The team is focused on improving the open‑source tooling before pursuing monetization. With the seed funding they plan to add features, reach beta, and ship version 1.0.